| Self-report measures of parental self-efficacy: A systematic review of the current literature A Wittkowski, C Garrett, R Calam, D Weisberg Journal of child and family studies 26, 2960-2978, 2017 | 317 | 2017 |
| Children’s thinking about their own and others’ regret and relief DP Weisberg, SR Beck Journal of Experimental Child Psychology 106 (2-3), 184-191, 2010 | 116 | 2010 |
| The development of children's regret and relief DP Weisberg, SR Beck Cognition & emotion 26 (5), 820-835, 2012 | 98 | 2012 |
| A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome S Cuvertino, V Hartill, A Colyer, T Garner, N Nair, L Al-Gazali, N Canham, ... Genetics in Medicine 22 (5), 867-877, 2020 | 51 | 2020 |
| Conditional reasoning and emotional experience: A review of the development of counterfactual thinking SR Beck, DP Weisberg, P Burns, KJ Riggs Studia Logica 102, 673-689, 2014 | 42 | 2014 |
| High dose genistein in Sanfilippo syndrome: A randomised controlled trial A Ghosh, S Rust, K Langford‐Smith, D Weisberg, M Canal, C Breen, ... Journal of Inherited Metabolic Disease 44 (5), 1248-1262, 2021 | 28 | 2021 |
| Perceived fatigue in children and young adults with neurofibromatosis type 1 G Vassallo, Z Mughal, L Robinson, D Weisberg, SA Roberts, E Hupton, ... Journal of paediatrics and child health 56 (6), 878-883, 2020 | 14 | 2020 |
| Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: trial in progress-NCT04201405 JL Kinsella, RF Wynn, B Bigger, AJ Thrasher, C Booth, K Buckland, ... Blood 136, 15-16, 2020 | 4 | 2020 |
| Ex-vivo autologous stem cell gene therapy clinical trial for mucopolysaccharidosis type IIIA: Update on phase I/II clinical trial JL Kinsella, S Jones, AJ Thrasher, C Booth, KF Buckland, N Izotova, ... Molecular Genetics and Metabolism 132 (2), S56-S57, 2021 | 2 | 2021 |
| High dose genistein aglycone in Sanfilippo syndrome: results of a randomized, double-blinded, placebo controlled clinical trial A Ghosh, S Rust, M Canal, D Weisberg, M Hepburn, K Tylee, BW Bigger, ... Molecular Genetics and Metabolism 126 (2), S59-S60, 2019 | 2 | 2019 |
| High dose genistein aglycone in Sanfilippo syndrome: Results of a randomised, double-blinded, placebo controlled clinical trial A Ghosh, S Rust, D Weisberg, M Canal, FA Wijburg, FM Vaz, KL Tylee, ... Molecular Genetics and Metabolism 123 (2), S51-S52, 2018 | 2 | 2018 |
| Biochemical engraftment and clinical outcomes following ex-vivo autologous stem cell gene therapy for mucopolysaccharidosis type IIIA RF Wynn, JL Kinsella, RJ Holley, J Potter, AJ Thrasher, C Booth, ... Blood 140 (Supplement 1), 1897-1898, 2022 | 1 | 2022 |
| Correction: A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct from Kabuki syndrome S Cuvertino, V Hartill, A Colyer, T Garner, N Nair, L Al-Gazali, N Canham, ... Genetics in Medicine 22 (5), 980-980, 2020 | 1 | 2020 |
| BIOCHEMICAL ENGRAFTMENT AND CLINICAL OUTCOMES OF EX-VIVO AUTOLOGOUS STEM CELL GENE THERAPY FOR MUCOPOLYSACCHARIDOSIS TYPE IIIA A Guha, R Wynn, B Bigger, J Kinsella, R Holley, J Potter, S Ellison, ... BONE MARROW TRANSPLANTATION 58 (SUPP 1), 62-63, 2023 | | 2023 |
| Clinical trial update: ex vivo autologous stem cell gene therapy in MPSIIIA JL Kinsella, JE Potter, SA Jones, AJ Thrasher, C Booth, KF Buckland, ... BONE MARROW TRANSPLANTATION 57 (SUPPL 1), 56-57, 2022 | | 2022 |
| Clinical trial update: Ex-vivo autologous hematopoietic stem cell gene therapy in MPS IIIA SA Jones, JL Kinsella, J Potter, A Thrasher, C Booth, K Buckland, ... Molecular Genetics and Metabolism 135 (2), S63-S64, 2022 | | 2022 |
| Neurocognitive outcome in mucopolysaccharidosis type 1 (Hurler phenotype) post HSCT A Broomfield, K Kodituwakku, J Mercer, R Wynn, S Rust, B Schwahn, ... Molecular Genetics and Metabolism 135 (2), S26-S27, 2022 | | 2022 |
| Clinical Trial Update: Ex-vivo autologous haematopoietic stem cell gene therapy in MPSIIIA SA Jones, JL Kinsella, J Potter, AJ Thrasher, C Booth, KF Buckland, ... HUMAN GENE THERAPY 32 (19-20), A139-A140, 2021 | | 2021 |
| Clinical Trial Update: EX-VIVO Autologous Stem Cell Gene Therapy in MPSIIIA JL Kinsella, SA Jones, AJ Thrasher, C Booth, KF Buckland, N Izotova, ... BONE MARROW TRANSPLANTATION 56 (SUPPL 1), 68-69, 2021 | | 2021 |
| A restricted spectrum of missense KMT2D variants cause a multiple malformations disorder distinct fromKabuki syndrome C Sara, H Verity, A Colyer, T Garner, N Nair, AG Lihadh, N Canham, ... Genetics in Medicine 22 (5), 867-877, 2020 | | 2020 |
Sarah Ruth BeckProfessor of Cognitive Development, University of Birmingham, UKVerified email at bham.ac.uk
